Takeda Heads to Shire Vote With Backing from EU, Advisory Groups

(Bloomberg) -- The fate of Takeda Pharmaceutical Co.’s $62 billion acquisition of Shire Plc now rests with shareholders after Japan’s biggest overseas deal successfully cleared all the regulatory h...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.